Coronavirus News Roundup: FDA Reports Safety and Efficacy for Johnson & Johnson Vaccine, Pharmacist Leads COVID-19 Vaccine Clinics
Here’s a roundup of the latest coronavirus-related news.
This week marked 500,000 coronavirus-related deaths in the United States. The COVID-19 vaccination effort is well underway in the US, with over 68.27 million administered doses and 6.8% of the population fully vaccinated against the virus as of press time.
This week, an FDA advisory board confirmed the safety and efficacy of Johnson & Johnson’s COVID-19 vaccine candidate, and experts weigh in on how pharmacists can effectively tackle vaccination programs.
Here’s a roundup of the latest coronavirus-related news:
FDA Panel Endorses Johnson & Johnson's COVID-19 Vaccine for EUA
On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.
The Impact of COVID-19 on Pharmacy Management and Compliance
Pharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.
FDA Analysis of Johnson & Johnson COVID-19 Vaccine Confirms Safety, Efficacy
On Wednesday, the FDA released results of an analysis for Johnson & Johnson’s COVID-19 vaccine candidate that supports its authorization for emergency use.
Regulation and Cost Considerations for Pharmacists Administering COVID-19 Vaccines
In our final interview segment, Lee Rosebush dives into improving vaccine distribution, addressing costs, and maintaining records while vaccinating for COVID-19.
Part 2: Pharmacist Leads COVID-19 Vaccination Clinic
In part 2 of our interview, Kaitlyn Rivard, PharmD, leads an insightful discussion on the practical side of administering COVID-19 vaccines.
MJH COVID-19 Coalition Provides Perspectives on Vaccine Rollout, Double Masking
Members of the MJH Life Sciences™ COVID-19 Coalition recently weighed in on the latest COVID-19 pandemic news.
Avoid Regulation Issues With This State-By-State COVID-19 Vaccination Guide
Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.
AAP letter urges the start of COVID-19 vaccine trials in young children
A safe COVID-19 vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
